Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/Signaling.3.062
The Outcome of Tumor Ablation Therapies is Determined by Stress Signaling Networks
Mladen Korbelik1,*
- 1Integrative Oncology Department, BC Cancer, Vancouver, BC, Canada
Corresponding Author
Prof. Dr. Mladen Korbelik, mkorbelik@bccrc.ca
Received Date: November 26, 2021
Accepted Date: January 05, 2022
Korbelik M. The Outcome of Tumor Ablation Therapies is Determined by Stress Signaling Networks. J Cell Signal. 2022;3(1):1-4.
Copyright: © 2022 Korbelik M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy
Cell Death has long been considered to be an inevitable part of the life cycle of a cell and hence, considered a familiar consequence of cellular life.
The Outcome of Tumor Ablation Therapies is Determined by Stress Signaling Networks
Increasingly prominent roles in interventional oncology are held by various tumor ablation therapies performed by direct applications of local acute trauma-inducing insult to the targeted lesion aiming for its rapid in situ destruction. These therapies include treatments based on various forms of thermal energy delivery (photothermal, cryoablation, microwave ablation, radiofrequency ablation), non-thermal illumination (photodynamic therapy), electric field exposure, or high hydrostatic pressure
Commentary on “A Vaccine for Photodynamic Immunogenic Cell Death: Tumor Cell Caged b y Cellular Disulfide–Thiol Exchange for Immunotherapy”
Tumor immunotherapy, including monoclonal antibody of immune checkpoint blockade, therapeutic antibody, cancer vaccine and cell therapy, etc., is to restart and maintain the tumor immune cycle, restore the normal antitumor immune response of the body, so as to control and eliminate the tumor.